A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies

被引：0
|
作者：
Carrico, C. T. [1 ]
Lagerquist, E. [2 ]
Boni, E. [3 ]
Ban, Y. A. [1 ]
Bretz, C. [3 ]
Ellingson, K. [2 ]
Kalyuzhniy, O. [1 ]
Montefiori, D. [4 ]
Strong, R. [3 ]
Stamatatos, L. [2 ]
Schief, W. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Seattle Biomed Res Inst, Seattle, WA 98109 USA
[3] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[4] Duke Univ, Durham, NC USA
来源：
RETROVIROLOGY | 2009年 / 6卷
关键词：
Surface Plasmon Resonance; Scaffold Protein; Computational Design; Modeling Platform; Structural Search;
D O I：
10.1186/1742-4690-6-S3-P88
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals
    Andrabi, Raiees
    Williams, Constance
    Wang, Xiao-Hong
    Li, Liuzhe
    Choudhary, Alok K.
    Wig, Naveet
    Biswas, Ashutosh
    Luthra, Kalpana
    Nadas, Arthur
    Seaman, Michael S.
    Nyambi, Phillipe
    Zolla-Pazner, Susan
    Gorny, Miroslaw K.
    VIROLOGY, 2013, 439 (02) : 81 - 88
  • [32] P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
    S Zolla-Pazner
    T Wrin
    MS Seaman
    X Yu
    B Wood
    S Self
    CE Hioe
    Retrovirology, 6
  • [33] Neutralization efficiency and presence of anti-V3 antibodies in plasma of HIV-1 infected Northern Indians
    Choudhary, Alok K.
    Dutta, Subhashree
    Wig, Naveet
    Biswas, A.
    Andrabi, Raiees
    Kalra, Rajesh
    Bhasin, Rama
    Pazner, Susan Zolla
    Laal, Suman
    Luthra, Kalpana
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 : 160 - 160
  • [34] Fate of anti-gp120 and anti-V3 antibodies (Abs) during therapy of HIV infection with Indinavir.
    Morrison, SA
    Govek, EE
    Shen, Y
    Steigbigel, RT
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 128 - 128
  • [35] COMPARATIVE IMMUNOGENICITY OF GP120-DERIVED PROTEINS AND THEIR INDUCTION OF ANTI-V3 LOOP REGION ANTIBODIES
    KLINMAN, DM
    STEIMER, KS
    CONOVER, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1992, 5 (10): : 1005 - 1008
  • [36] Human immunodeficiency virus type 1 evasion of a neutralizing anti-V3 antibody involves acquisition of a potential glycosylation site in V2
    Hatada, Makiko
    Yoshimura, Kazuhisa
    Harada, Shigeyoshi
    Kawanami, Yoko
    Shibata, Junji
    Matsushita, Shuzo
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 1335 - 1345
  • [37] A designed Tat immunogen generates enhanced anti-Tat C-terminal antibodies
    Liao, Wenting
    Chen, Qiuli
    Cao, Jie
    Tan, Guangguo
    Zhu, Zhenyu
    Zhang, Huaqun
    Chai, Yifeng
    Pan, Wei
    VACCINE, 2012, 30 (14) : 2453 - 2461
  • [38] LACK OF ASSOCIATION BETWEEN ANTI-V3 LOOP ANTIBODIES AND PERINATAL TRANSMISSION OF HIV-1 IN KAMPALA, UGANDA
    EPSTEIN, H
    GUAY, L
    HOM, D
    MMIRO, F
    NDUGWA, C
    MARUM, L
    OLNESS, K
    PIWOWAR, E
    KATAAHA, P
    BAENZIGER, J
    JACKSON, JB
    PEDIATRIC AIDS AND HIV INFECTION-FETUS TO ADOLESCENT, 1994, 5 (06): : 350 - 356
  • [39] Structural Basis of the Antibody-Antigen Interaction in Human Anti-V3 HIV-1 Monoclonal Antibodies
    Jiang, X.
    Burke, V.
    Williams, C.
    Gorny, M. K.
    Zolla-Pazner, S.
    Kong, X.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 11 - 11
  • [40] A MONOCLONAL ANTIIDIOTYPE ANTIBODY ELICITS BROADLY NEUTRALIZING ANTI-GP120 ANTIBODIES IN MONKEYS
    KANG, CY
    NARA, P
    CHAMAT, S
    CARALLI, V
    CHEN, A
    NGUYEN, ML
    YOSHIYMA, H
    MORROW, WJW
    HO, DD
    KOHLER, H
    FASEB JOURNAL, 1992, 6 (05): : A1725 - A1725
12345